Jacobs IJ - Search Results

1

Molecular assessment of depth of myometrial invasion in stage I endometrial cancer: a model based on K-ras mutation analysis.

Alexander-Sefre F, Salvesen HB, Ryan A, Singh N, Akslen LA, MacDonald N, Wilbanks G, Jacobs IJ. Alexander-Sefre F, et al. Among authors: jacobs ij. Gynecol Oncol. 2003 Oct;91(1):218-25. doi: 10.1016/s0090-8258(03)00505-5. Gynecol Oncol. 2003. PMID: 14529685

2

No evidence exists for methylation inactivation of the p16 tumor suppressor gene in ovarian carcinogenesis.

Ryan A, Al-Jehani RM, Mulligan KT, Jacobs IJ. Ryan A, et al. Among authors: jacobs ij. Gynecol Oncol. 1998 Jan;68(1):14-7. doi: 10.1006/gyno.1997.4881. Gynecol Oncol. 1998. PMID: 9454653

3

Model for the molecular genetic diagnosis of endometrial cancer using K-ras mutation analysis.

Al-Jehani RM, Jeyarajah AR, Hagen B, Hogdall EV, Oram DH, Jacobs IJ. Al-Jehani RM, et al. Among authors: jacobs ij. J Natl Cancer Inst. 1998 Apr 1;90(7):540-2. doi: 10.1093/jnci/90.7.540. J Natl Cancer Inst. 1998. PMID: 9539251 No abstract available.

4

p53 codon 72 polymorphism and risk of cervical cancer in UK.

Rosenthal AN, Ryan A, Al-Jehani RM, Storey A, Harwood CA, Jacobs IJ. Rosenthal AN, et al. Among authors: jacobs ij. Lancet. 1998 Sep 12;352(9131):871-2. doi: 10.1016/S0140-6736(98)07357-7. Lancet. 1998. PMID: 9742979

5

Screening for ovarian cancer.

MacDonald ND, Rosenthal AN, Jacobs IJ. MacDonald ND, et al. Among authors: jacobs ij. Ann Acad Med Singap. 1998 Sep;27(5):676-82. Ann Acad Med Singap. 1998. PMID: 9919339 Review.

6

Is there a place for screening in ovarian cancer?

MacDonald ND, Jacobs IJ. MacDonald ND, et al. Among authors: jacobs ij. Eur J Obstet Gynecol Reprod Biol. 1999 Feb;82(2):155-7. doi: 10.1016/s0301-2115(98)00219-x. Eur J Obstet Gynecol Reprod Biol. 1999. PMID: 10206408 Review. No abstract available.

7

Screening for ovarian cancer: a pilot randomised controlled trial.

Jacobs IJ, Skates SJ, MacDonald N, Menon U, Rosenthal AN, Davies AP, Woolas R, Jeyarajah AR, Sibley K, Lowe DG, Oram DH. Jacobs IJ, et al. Lancet. 1999 Apr 10;353(9160):1207-10. doi: 10.1016/S0140-6736(98)10261-1. Lancet. 1999. PMID: 10217079 Clinical Trial.

8

Increased mortality in postmenopausal women with serum CA125 elevation.

Jeyarajah AR, Ind TE, MacDonald N, Skates S, Oram DH, Jacobs IJ. Jeyarajah AR, et al. Among authors: jacobs ij. Gynecol Oncol. 1999 May;73(2):242-6. doi: 10.1006/gyno.1999.5350. Gynecol Oncol. 1999. PMID: 10329041 Clinical Trial.

9

Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation.

Menon U, Talaat A, Jeyarajah AR, Rosenthal AN, MacDonald ND, Skates SJ, Sibley K, Oram DH, Jacobs IJ. Menon U, et al. Among authors: jacobs ij. Br J Cancer. 1999 Jul;80(10):1644-7. doi: 10.1038/sj.bjc.6690575. Br J Cancer. 1999. PMID: 10408412 Free PMC article.

10

Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations.

Zweemer RP, Shaw PA, Verheijen RM, Ryan A, Berchuck A, Ponder BA, Risch H, McLaughlin JR, Narod SA, Menko FH, Kenemans P, Jacobs IJ. Zweemer RP, et al. Among authors: jacobs ij. J Clin Pathol. 1999 May;52(5):372-5. doi: 10.1136/jcp.52.5.372. J Clin Pathol. 1999. PMID: 10560359 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters